CIK 0001671502 · Non-accelerated filer<br>Smaller reporting company
Quoin Pharmaceuticals Ltd.
Sign in to watch- Ticker
- QNRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- Incorporated
- Israel
- Entity type
- operating
- Phone
- 703 980 4182
- Business address
- 42127 PLEASANT FOREST COURT, ASHBURN, VA, 20148-7349
- Former names
- Quoin Pharmaceuticals, Ltd., Cellect Biotechnology Ltd., Cellect Biomed Ltd.
- Open-market buys, last 90 days
- $279,966
- in 4 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$279,966. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-31 | Carter Denise P. Chief Operating Officer | Purchase | +20,490 | $4.88 | $100K | 37,709 |
| 2026-08-31 | Myers Michael Chief Executive Officer | Purchase | +20,490 | $4.88 | $100K | 37,713 |
| 2026-08-31 | Lawlor Sally Bridget Chief Financial Officer | Purchase | +10,244 | $4.88 | $50K | 10,684 |
| 2026-08-31 | Culverwell Anthony James Director | Purchase | +6,146 | $4.88 | $30K | 40,364 |
| 2025-10-14 | LANGER DENNIS Director | Purchase | +15,152 | $8.49 | $129K | 15,153 |
| 2024-12-23 | Carter Denise P. Chief Operating Officer | Purchase | +555,556 | $0.45 | $250K | 602,648 |
| 2024-12-23 | Myers Michael Chief Executive Officer | Purchase | +555,556 | $0.45 | $250K | 602,808 |
| 2024-12-23 | Dunn Gordon Chief Financial Officer | Purchase | +122,221 | $0.45 | $55K | 151,077 |
| 2024-12-23 | Culverwell Anthony James Director | Purchase | +100,000 | $0.45 | $45K | 100,317 |
| 2024-09-10 | Dunn Gordon Chief Financial Officer | Purchase | +10,000 | $0.91 | $9K | 18,856 |
| 2024-09-10 | Dunn Gordon Chief Financial Officer | Purchase | +10,000 | $0.71 | $7K | 28,856 |
| 2024-09-09 | Dunn Gordon Chief Financial Officer | Purchase | +856 | $0.80 | $685 | 856 |
| 2024-09-09 | Dunn Gordon Chief Financial Officer | Purchase | +4,000 | $0.78 | $3K | 4,856 |
| 2024-09-09 | Dunn Gordon Chief Financial Officer | Purchase | +4,000 | $0.80 | $3K | 8,856 |
| 2024-09-04 | Carter Denise P. Chief Operating Officer | Purchase | +8,825 | $0.75 | $7K | 24,104 |
| 2024-09-04 | Carter Denise P. Chief Operating Officer | Purchase | +22,988 | $0.80 | $18K | 47,092 |
| 2024-09-04 | Myers Michael Chief Executive Officer | Purchase | +5,322 | $0.66 | $3K | 15,480 |
| 2024-09-04 | Myers Michael Chief Executive Officer | Purchase | +8,200 | $0.75 | $6K | 23,680 |
| 2024-09-04 | Myers Michael Chief Executive Officer | Purchase | +23,572 | $0.80 | $19K | 47,252 |
| 2024-09-03 | Carter Denise P. Chief Operating Officer | Purchase | +1,822 | $0.63 | $1K | 11,179 |
Page 1 of 2 · 22 trades